World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
28099
World Ranking
3769
National Ranking
1726

Overview

W. Nicholas Haining is affiliated with Arsenal Biosciences in the United States. Their research spans several interdisciplinary fields including Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Subfields of study prominently featured in their work include Immunology, Oncology, Molecular Biology, Biomedical Engineering, and Public Health, Environmental and Occupational Health.

The scientist's research primarily focuses on topics related to CAR-T cell therapy, Immune Cell Function and Interaction, CRISPR and Genetic Engineering, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, as well as Immune cells in cancer.

Recent significant publications by W. Nicholas Haining include:

  • Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity, 2021, Nature
  • Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans, 2021, Nature Immunology
  • In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer, 2022, Nature Immunology
  • The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection, 2020, Cell Reports
  • PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment, 2022, Journal for ImmunoTherapy of Cancer

W. Nicholas Haining frequently collaborates with several researchers. Notable co-authors include Kathleen B. Yates, Levi Gray-Rupp, Aaron Cooper, Debattama R. Sen, and Suchismita Mohanty.

The scientist has published extensively in journals such as:

  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Nature Immunology
  • Cancer Immunology Research
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

    E. John Wherry;Sang Jun Ha;Susan M. Kaech;W. Nicholas Haining

  • Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

    Shawn D Blackburn;Haina Shin;W Nicholas Haining;W Nicholas Haining;Tao Zou

  • Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.

    Brian C. Miller;Debattama R. Sen;Debattama R. Sen;Rose Al Abosy;Rose Al Abosy;Kevin Bi;Kevin Bi

  • Defining ‘T cell exhaustion’

    Christian U Blank;W Nicholas Haining;Werner Held;Patrick G Hogan;Patrick G Hogan

  • Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

    Kristen E. Pauken;Morgan A. Sammons;Pamela M. Odorizzi;Sasikanth Manne

  • In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

    Robert T. Manguso;Robert T. Manguso;Hans W. Pope;Hans W. Pope;Margaret D. Zimmer;Margaret D. Zimmer;Flavian D. Brown

  • Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis

    Noa Novershtern;Noa Novershtern;Noa Novershtern;Aravind Subramanian;Lee N. Lawton;Raymond H. Mak

  • Normalizing the environment recapitulates adult human immune traits in laboratory mice

    Lalit K. Beura;Sara E. Hamilton;Kevin Bi;Jason M. Schenkel

  • The epigenetic landscape of T cell exhaustion

    Debattama R. Sen;James Kaminski;R. Anthony Barnitz;Makoto Kurachi

  • PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.

    Vikram R. Juneja;Vikram R. Juneja;Vikram R. Juneja;Kathleen A. McGuire;Kathleen A. McGuire;Robert T. Manguso;Martin W. LaFleur;Martin W. LaFleur

  • Systems biology of vaccination for seasonal influenza in humans

    Helder Imoto Nakaya;Jens Wrammert;Eva K Lee;Luigi Racioppi;Luigi Racioppi

  • Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates

    Surojit Sarkar;Vandana Kalia;W. Nicholas Haining;Bogumila T. Konieczny

  • CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

    Jiehui Deng;Jiehui Deng;Eric S. Wang;Russell W. Jenkins;Shuai Li

  • Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo

    Vandana Kalia;Surojit Sarkar;Shruti Subramaniam;W. Nicholas Haining

  • Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.

    Jeffrey J. Ishizuka;Jeffrey J. Ishizuka;Robert T. Manguso;Robert T. Manguso;Collins K. Cheruiyot;Collins K. Cheruiyot;Kevin Bi;Kevin Bi

  • Transcriptional analysis of HIV-specific CD8 + T cells shows that PD-1 inhibits T cell function by upregulating BATF

    Michael Quigley;Florencia Pereyra;Björn Nilsson;Filippos Porichis

  • Origin and differentiation of human memory CD8 T cells after vaccination

    Rama Akondy;Mark Fitch;Srilatha Edupuganti;Shu Yang

  • Stable inhibitory activity of regulatory T cells requires the transcription factor Helios

    Hye-Jung Kim;R. Anthony Barnitz;R. Anthony Barnitz;Taras Kreslavsky;Flavian D. Brown

  • CD39 Expression Identifies Terminally Exhausted CD8+ T Cells

    Prakash K. Gupta;Prakash K. Gupta;Jernej Godec;Jernej Godec;David Wolski;Emily Adland

  • The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells

    Makoto Kurachi;R Anthony Barnitz;Nir Yosef;Pamela M Odorizzi

  • Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection (DOI:10.1016/j.immuni.2007.09.006)

    E. John Wherry;Sang Jun Ha;Susan M. Kaech;W. Nicholas Haining

Frequent Co-Authors

Arlene H. Sharpe
Arlene H. Sharpe Harvard University
E. John Wherry
E. John Wherry University of Pennsylvania
Benjamin L. Ebert
Benjamin L. Ebert Harvard University
Lee M. Nadler
Lee M. Nadler Harvard University
Rafi Ahmed
Rafi Ahmed Emory University
Gordon J. Freeman
Gordon J. Freeman Harvard University
Todd R. Golub
Todd R. Golub Harvard University
Nir Yosef
Nir Yosef University of California, Berkeley
John G. Doench
John G. Doench Broad Institute
Paul Klenerman
Paul Klenerman University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to various allied healthcare and research careers. For many students interested in clinical applications, accelerated nursing programs provide a fast track into nursing roles, blending healthcare knowledge with biological sciences. Exploring accelerated nursing programs can be an excellent option for those looking to enter the field quickly while maintaining high standards.

For individuals without a nursing background, enrolling in online BSN programs for non nurses offers a flexible pathway to obtaining a Bachelor of Science in Nursing, which complements immunology expertise in patient care and treatment planning.

Once in nursing, advancing to specialized roles is possible through accelerated NP programs online, allowing professionals to focus on immunology-related specialties such as infectious diseases and immunotherapy.

Further, for those starting healthcare careers sooner, the best easiest LPN programs to get into offer accessible entry points, enabling individuals to begin working while continuing their education in immunology and related fields.

Best Scientists Citing W. Nicholas Haining

Trending Scientists